Diabetic Ketoacidosis as an Effect of Sodium-Glucose Cotransporter 2 Inhibitor: Real World Insights

Diabetic Ketoacidosis as an Effect of Sodium-Glucose Cotransporter 2 Inhibitor: Real World Insights

One of the notable adverse effects of sodium-glucose cotransporter 2 (SGLT2) inhibitor is diabetic ketoacidosis (DKA) often characterized by euglycemia. In this retrospective review of patients with DKA from 2015 to 2023, 21 cases of SGLT2 inhibitorassociated DKA were identified. Twelve (57.1%) exhi...

Full description

Bibliographic Details
Main Authors: Han-Sang Baek, Chaiho Jeong, Yeoree Yang, Joonyub Lee, Jeongmin Lee, Seung-Hwan Lee, Jae Hyoung Cho, Tae-Seo Sohn, Hyun-Shik Son, Kun-Ho Yoon, Eun Young Lee
Format: Article
Language:English
Published: Korean Diabetes Association 2024-11-01
Series:Diabetes & Metabolism Journal
Subjects:
diabetes mellitus
diabetic ketoacidosis
sodium-glucose transporter 2 inhibitors
Online Access:http://e-dmj.org/upload/pdf/dmj-2024-0036.pdf

Internet

http://e-dmj.org/upload/pdf/dmj-2024-0036.pdf

Similar Items